General Information of the Compound
| Compound ID |
CP0396444
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[[4-[[3-(3,5-dichlorophenyl)-5-[5-(trifluoromethoxy)naphthalen-2-yl]pyrazol-1-yl]methyl]benzoyl]amino]propanoic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H22Cl2F3N3O4
|
||||||||||||||||||
| Molecular Weight |
628.434
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)CCNC(=O)c1ccc(Cn2nc(cc2-c2ccc3c(OC(F)(F)F)cccc3c2)-c2cc(Cl)cc(Cl)c2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H22Cl2F3N3O4/c32-23-13-22(14-24(33)15-23)26-16-27(21-8-9-25-20(12-21)2-1-3-28(25)43-31(34,35)36)39(38-26)17-18-4-6-19(7-5-18)30(42)37-11-10-29(40)41/h1-9,12-16H,10-11,17H2,(H,37,42)(H,40,41)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WYWGZQRLUCSQFO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02242, Gastric inhibitory polypeptide receptor
Protein ID: PT01473, Glucagon receptor